Ann Surg Treat Res.  2015 Dec;89(6):295-299. 10.4174/astr.2015.89.6.295.

Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study

• Chai YJ
• Hong JH
• Koo DH
• Yu HW
• Lee JH
• Kwon H
• Kim SJ
• Choi JY
• Lee KE

• KMID: 2148303
• DOI: http://doi.org/10.4174/astr.2015.89.6.295

Abstract

PURPOSE
Primary thyroid lymphoma (PTL) is a rare disease and it has been investigated in a limited number of studies. The present multicenter study evaluated the clinical features and treatment outcomes of PTL.
METHODS
The medical records of patients diagnosed with PTL between 2000 and 2013 in three centers were retrospectively reviewed.
RESULTS
The study included 11 men and 27 women with a median age of 63.3 years (range, 42-83 years). The median follow-up was 56.0 months (range, 3-156 months). Of the 38 patients included, 16 had mucosa-associated lymphoid tissue (MALT) lymphoma, six had mixed MALT and diffuse large B-cell lymphoma (DLBCL), and 16 had DLBCL. Thirty-five patients (92.1%) had early stage (stage I/II) disease. Of the 16 MALT lymphoma patients, 14 were treated by surgery, and radiotherapy (RT) or chemotherapy was combined in five patients. Two patients received RT or chemotherapy alone. Of the six mixed MALT and DLBCL patients, three underwent surgery with chemotherapy and three underwent chemotherapy alone, RT alone, or surgery with RT. All of the 16 DLBCL patients received chemotherapy, and surgery and RT was combined in 4 and 1 patients, respectively. The 5-year survival was 100% for MALT lymphoma (7 of 7) and mixed MALT and DLBCL patients (5 of 5) and 87.5% for DLBCL patients (7 of 8).
CONCLUSION
Early stage PTL has an excellent prognosis when managed by single or combined treatment modalities. Clinicians should consider PTL in patients with underlying Hashimoto's thyroiditis presenting with an enlarging thyroid mass.

Keyword

Lymphoma; Thyroid lymphoma; Primary thyroid lymphoma; Marginal zone B-cell lymphoma; Diffuse Large B-cell lymphoma

MeSH Terms

Drug Therapy
Female
Follow-Up Studies
Humans
Lymphoid Tissue
Lymphoma*
Lymphoma, B-Cell
Lymphoma, B-Cell, Marginal Zone
Male
Medical Records
Prognosis
Radiotherapy
Rare Diseases
Retrospective Studies
Thyroid Gland*
Thyroiditis

Reference

1. Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol. 2000; 24:623–639.

2. Widder S, Pasieka JL. Primary thyroid lymphomas. Curr Treat Options Oncol. 2004; 5:307–313.

3. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol. 1999; 26:316–323.

4. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985; 312:601–604.

5. Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka F, Kuma K, et al. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res. 1985; 76:1085–1090.

6. Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Surgery. 2009; 146:1105–1115.

7. Alzouebi M, Goepel JR, Horsman JM, Hancock BW. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol. 2012; 40:2075–2080.

8. Kumar R, Khosla D, Kumar N, Ghoshal S, Bera A, Das A, et al. Survival and failure outcomes in primary thyroid lymphomas: a single centre experience of combined modality approach. J Thyroid Res. 2013; 2013:269034.

9. Green LD, Mack L, Pasieka JL. Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. J Surg Oncol. 2006; 94:725–736.

10. Matsuda M, Sone H, Koyama H, Ishiguro S. Fine-needle aspiration cytology of malignant lymphoma of the thyroid. Diagn Cytopathol. 1987; 3:244–249.

11. Sakorafas GH, Kokkoris P, Farley DR. Primary thyroid lymphoma (correction of lympoma): diagnostic and therapeutic dilemmas. Surg Oncol. 2010; 19:e124–e129.

12. Belal AA, Allam A, Kandil A, El Husseiny G, Khafaga Y, Al Rajhi N, et al. Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma. Am J Clin Oncol. 2001; 24:299–305.

13. Watanabe N, Noh JY, Narimatsu H, Takeuchi K, Yamaguchi T, Kameyama K, et al. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto\'s disease. Br J Haematol. 2011; 153:236–243.

14. Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003; 21:4157–4164.

15. Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002; 87:105–111.

16. Oh SY, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, et al. Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study. Acta Haematol. 2012; 127:100–104.

17. Pfreundschuh M, Schubert J, Ziepert M, Schmits R, Mohren M, Lengfelder E, et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol. 2008; 9:105–116.

18. Watanabe N, Narimatsu H, Noh JY, Kunii Y, Mukasa K, Matsumoto M, et al. Rituximab-including combined modality treatment for primary thyroid lymphoma: an effective regimen for elderly patients. Thyroid. 2014; 24:994–999.

19. Cha H, Kim JW, Suh CO, Kim JS, Cheong JW, Lee J, et al. Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study. Radiat Oncol J. 2013; 31:177–184.

20. Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto\'s thyroiditis. Hum Pathol. 1988; 19:1315–1326.

21. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19:1167–1214.

22. Mack LA, Pasieka JL. An evidence-based approach to the treatment of thyroid lymphoma. World J Surg. 2007; 31:978–986.

23. Stein SA, Wartofsky L. Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab. 2013; 98:3131–3138.

24. Nam M, Shin JH, Han BK, Ko EY, Ko ES, Hahn SY, et al. Thyroid lymphoma: correlation of radiologic and pathologic features. J Ultrasound Med. 2012; 31:589–594.